RxDoctor Payments Data

Carissa Peterson

Adult Health · Edgewater, FLNPI 1376097105

Payments from drug & device makers

$881in general payments, 2019–2025

Across 45 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • AstraZeneca$105
  • Novo Nordisk$96
  • Exact Sciences$75
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$66
  • Amgen$51
  • plus $136 from 6 others

What the payments were for

  • Food & beverage$83495%
  • Education$475%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$881 in reported general payments places this provider in the 60th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$13,580
Medicare patients
58
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$64,695
OzempicSemaglutide16$29,572
TrulicityDulaglutide23$26,402
MounjaroTirzepatide21$24,667
EliquisApixaban26$22,072
VraylarCariprazine Hcl13$21,223
LinzessLinaclotide21$17,072
VerquvoVericiguat14$10,836
JardianceEmpagliflozin12$10,603
MyrbetriqMirabegron11$9,682
SymbicortBudesonide/Formoterol Fumarate28$7,598
Repatha SureclickEvolocumab12$6,926
Synjardy XrEmpagliflozin/Metformin Hcl11$6,744
Omeprazole153$3,779
Albuterol Sulfate HfaAlbuterol Sulfate110$2,917

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$21$51,06944 claims
AbbVieVraylar, Linzess, Synthroid$352$39,28750 claims
Novo NordiskOzempic$96$29,57216 claims
AstraZenecaSymbicort$105$7,59828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,237 adult health providers in Florida.

Other adult health in Edgewater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →